Quantitative assessment of common genetic variants on FOXE1 and differentiated thyroid cancer risk

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zhu, Hongling ^a   Xi, Qian ^a   Liu, Lianyong ^a   Wang, Jingnan ^a   Gu, Mingjun ^a  

^a Shanghai Pudong New Area Gongli Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIFFERENTIATED THYROID CANCER; ETHNICITY; FOXE1 GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; ONCOGENE; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FORKHEAD TRANSCRIPTION FACTORS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THYROID NEOPLASMS;

EID: 84900416074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087332     Document Type: Article

References (40)

1. DeLellis RA (2004) Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press.pp 320.
2. Kondo T, Ezzat S, Asa SL (2006) Pathogenetic mechanisms in thyroid follicular cell neoplasia. Nat Rev Cancer 6: 292-306.
3. Schneider AB, Sarne DH (2005) Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metab 1: 82-91.
4. Hrafnkelsson J, Tulinius H, Jónasson JG, Sigvaldason H (2001) Familial nonmedullary thyroid cancer in Iceland. J Med Genet 38: 189-91.
5. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, et al. (2004) Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1: e65.
6. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, et al. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41: 460-4.
7. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, et al. (2012) Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet 44: 319-22.
8. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, et al. (2009) Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A 106: 1502-5.
9. Ruiz-Llorente S, Montero-Conde C, Milne RL, Moya CM, Cebrian A, et al. (2007) Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma. Cancer Res 67: 9561-7. (Pubitemid 47535947)
10. Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, et al. (2008) A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 68: 9982-6.
11. Kallel R, Belguith-Maalej S, Akdi A, Mnif M, Charfeddine I, et al. (2010) Genetic Investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma. Cancer Biomarkers 8: 43-51.
12. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Pérez L, Schiavi F, et al. (2009) The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5: e1000637.
13. McClellan J, King MC (2010) Genetic heterogeneity in human disease. Cell 141: 210-217.
14. Li D, Collier DA, He L (2006) Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15: 1995-2002. (Pubitemid 43983273)
15. Wu S, Cai J, Wang H, Zhang H, Yang W (2013) Association between 1p11-rs11249433 Polymorphism and Breast Cancer Susceptibility: Evidence from 15 Case-Control Studies. PLoS One 8: e72526.
16. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
19. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19: 251-253.
20. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
21. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
22. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, et al. (2010) The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19: 2516-23.
23. Matsuse M, Takahashi M, Mitsutake N, Nishihara E, Hirokawa M, et al. (2011) The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet 48: 645-8.
24. Denny JC, Crawford DC, Ritchie MD, Bielinski SJ, Basford MA, et al. (2011) Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet 89: 529-42.
25. Tomaz RA, Sousa I, Silva JG, Santos C, Teixeira MR, et al. (2012) FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin Endocrinol (Oxf) 77: 926-33.
26. Bullock M, Duncan EL, O'Neill C, Tacon L, Sywak M, et al. (2012) Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J Clin Endocrinol Metab 97: E1814-9.
27. Jones AM, Howarth KM, Martin L, Gorman M, Mihai R, et al. (2012) Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet 49: 158-63.
28. Wang YL, Feng SH, Guo SC, Wei WJ, Li DS, et al. (2013) Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. J Med Genet 50: 689-95.
29. Liyanarachchi S, Wojcicka A, Li W, Czetwertynska M, Stachlewska E, et al. (2013) Cumulative Risk Impact of Five Genetic Variants Associated with Papillary Thyroid Carcinoma. Thyroid. doi: 10.1089/thy.2013.0102
30. Köhler A, Chen B, Gemignani F, Elisei R, Romei C, et al. (2013) Genome-wide association study on differentiated thyroid cancer. J Clin Endocrinol Metab. 98: E1674-81.
31. Damiola F, Byrnes G, Moissonnier M, Pertesi M, Deltour I, et al. (2013) Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation. Int J Cancer doi:10.1002/ijc.28483
32. Hemminki K, Lorenzo Bermejo J, Försti A (2006) The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 7: 958-65. (Pubitemid 44871399)
33. Zhou B, Song Z, Qian M, Li L, Gong J, et al. (2013) Functional Polymorphisms in the CYP2C19 Gene Contribute to Digestive System Cancer Risk: Evidence from 11,042 Subjects. PLoS One 8: e66865.
34. Williams D (2002) Cancer after nuclear fallout: lessons from the Chernobyl accident. Nat Rev Cancer 2: 543-549.
35. Dathan N, Parlato R, Rosica A, De Felice M, Di Lauro R (2002) Distribution of the titf2/foxe1 gene product is consistent with an important role in the development of foregut endoderm, palate, and hair. Dev Dyn 224: 450-6. (Pubitemid 34848069)
36. De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, et al. (1998) A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 19: 395-8. (Pubitemid 28357915)
37. Parlato R, Rosica A, Rodriguez-Mallon A, Affuso A, Postiglione MP, et al. (2004) An integrated regulatory network controlling survival and migration in thyroid organogenesis. Dev Biol 276: 464-75. (Pubitemid 39592407)
38. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John R, et al. (1998) Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 19: 399-401. (Pubitemid 28357916)
39. Sequeira MJ, Morgan JM, Fuhrer D, Wheeler MH, Jasani B, et al. Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid 11: 995-1001.
40. Carré A, Castanet M, Sura-Trueba S, Szinnai G, Van Vliet G, et al. (2007) Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum Genet 122: 467-76. (Pubitemid 350148958)